IOL CHEMICALS & PHARM. | JAGSON PHAR | IOL CHEMICALS & PHARM./ JAGSON PHAR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 34.3 | 38.3% | View Chart |
P/BV | x | 1.5 | 5.6 | 26.7% | View Chart |
Dividend Yield | % | 1.0 | 1.6 | 66.3% |
IOL CHEMICALS & PHARM. JAGSON PHAR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
JAGSON PHAR Mar-23 |
IOL CHEMICALS & PHARM./ JAGSON PHAR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 420 | 127.7% | |
Low | Rs | 272 | 254 | 107.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 90.3 | 418.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 10.2 | 232.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 10.7 | 296.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 5.00 | 80.0% | |
Avg Dividend yield | % | 1.0 | 1.5 | 66.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 57.3 | 448.2% | |
Shares outstanding (eoy) | m | 58.71 | 26.20 | 224.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.7 | 28.7% | |
Avg P/E ratio | x | 17.1 | 33.1 | 51.6% | |
P/CF ratio (eoy) | x | 12.8 | 31.6 | 40.5% | |
Price / Book Value ratio | x | 1.6 | 5.9 | 26.8% | |
Dividend payout | % | 16.9 | 49.0 | 34.4% | |
Avg Mkt Cap | Rs m | 23,743 | 8,831 | 268.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 652 | 258.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,367 | 936.6% | |
Other income | Rs m | 256 | 57 | 446.6% | |
Total revenues | Rs m | 22,427 | 2,424 | 925.0% | |
Gross profit | Rs m | 2,257 | 307 | 735.3% | |
Depreciation | Rs m | 462 | 12 | 3,830.7% | |
Interest | Rs m | 165 | 4 | 3,987.9% | |
Profit before tax | Rs m | 1,887 | 348 | 542.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 81 | 612.2% | |
Profit after tax | Rs m | 1,391 | 267 | 520.7% | |
Gross profit margin | % | 10.2 | 13.0 | 78.5% | |
Effective tax rate | % | 26.2 | 23.2 | 113.0% | |
Net profit margin | % | 6.3 | 11.3 | 55.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,722 | 561.4% | |
Current liabilities | Rs m | 5,025 | 352 | 1,428.3% | |
Net working cap to sales | % | 20.9 | 57.9 | 36.2% | |
Current ratio | x | 1.9 | 4.9 | 39.3% | |
Inventory Days | Days | 43 | 9 | 459.4% | |
Debtors Days | Days | 8 | 32 | 25.8% | |
Net fixed assets | Rs m | 11,017 | 304 | 3,625.7% | |
Share capital | Rs m | 587 | 131 | 448.2% | |
"Free" reserves | Rs m | 14,490 | 1,370 | 1,057.5% | |
Net worth | Rs m | 15,077 | 1,501 | 1,004.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 2,026 | 1,021.1% | |
Interest coverage | x | 12.5 | 85.3 | 14.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.2 | 91.7% | |
Return on assets | % | 7.5 | 13.4 | 56.2% | |
Return on equity | % | 9.2 | 17.8 | 51.8% | |
Return on capital | % | 13.6 | 23.5 | 58.0% | |
Exports to sales | % | 26.7 | 2.3 | 1,145.3% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 55 | 10,727.4% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 55 | 10,727.4% | |
Fx outflow | Rs m | 6,052 | 41 | 14,774.9% | |
Net fx | Rs m | -122 | 14 | -849.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 467 | 262.1% | |
From Investments | Rs m | -1,200 | -577 | 208.1% | |
From Financial Activity | Rs m | -41 | -5 | 899.3% | |
Net Cashflow | Rs m | -18 | -115 | 16.0% |
Indian Promoters | % | 48.2 | 24.9 | 193.5% | |
Foreign collaborators | % | 0.0 | 43.6 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.4 | 125.9% | |
FIIs | % | 1.4 | 0.5 | 264.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 31.5 | 164.4% | |
Shareholders | 130,003 | 15,785 | 823.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | JAGSON PHAR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -1.06% | -0.44% |
1-Month | -4.51% | 11.54% | 2.15% |
1-Year | -4.09% | -11.85% | 49.82% |
3-Year CAGR | -12.01% | 59.53% | 14.21% |
5-Year CAGR | 15.35% | 65.63% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the JAGSON PHAR share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of JAGSON PHAR the stake stands at 68.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of JAGSON PHAR.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
JAGSON PHAR paid Rs 5.0, and its dividend payout ratio stood at 49.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of JAGSON PHAR.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.